Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Other Non-Current Assets (2013 - 2026)

Scynexis' (SCYX) quarterly Other Non-Current Assets came in at $109000.0 in Q2 2026, down 73.86% on a YoY basis from $417000.0 in Q2 2025, and little changed quarter-over-quarter from $109000.0 in Q1 2026.

Analysis

Scynexis (SCYX) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has reported Other Non-Current Assets for 14 consecutive years, with $109000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Assets fell 73.86% year-over-year to $109000.0; the trailing twelve-month figure through Jun 2026 stood at $109000.0 (down 73.86% YoY), and the FY2025 full-year result was $533000.0, up 27.82% from the prior year.
  • Other Non-Current Assets steadied at $109000.0 in Q2 2026 per SCYX's latest filing, from $109000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $7.4 million in Q1 2023 and bottomed at $109000.0 in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $1.8 million across 5 years, with a median of $417000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets soared 701.01% in 2022, then slumped 97.65% in 2024.
  • Over 5 years, Other Non-Current Assets stood at $5.5 million in 2022, then sank by 96.82% to $175000.0 in 2023, then jumped by 138.29% to $417000.0 in 2024, then advanced by 27.82% to $533000.0 in 2025, then plunged by 79.55% to $109000.0 in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $109000.0, $109000.0, and $533000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 124.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 29.59 Mn
10 Scynexis 58.41 Mn -56.29 Mn - 109,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 109,000.00
Mar 31, 2026 109,000.00
Dec 31, 2025 533,000.00
Sep 30, 2025 417,000.00
Jun 30, 2025 417,000.00
Mar 31, 2025 417,000.00
Dec 31, 2024 417,000.00
Sep 30, 2024 187,000.00
Jun 30, 2024 175,000.00
Mar 31, 2024 175,000.00
Dec 31, 2023 175,000.00
Sep 30, 2023 164,000.00
Jun 30, 2023 163,000.00
Mar 31, 2023 7.44 Mn
Dec 31, 2022 5.51 Mn
Sep 30, 2022 5.08 Mn
Jun 30, 2022 6.08 Mn
Mar 31, 2022 5.54 Mn
Dec 31, 2021 6.24 Mn
Sep 30, 2021 1.37 Mn